Table 1.
Demographic characteristics of the study population.
| Clinical features | N total (n=627) | Count/mean ± SD |
|---|---|---|
| Age (mean ± SD) | 615 | 51.61 ± 12.68 |
| Sex | 626 | |
| Male | 339 | |
| Female | 287 | |
| BMI (mean ± SD) | 561 | 31.88 ± 6.32 |
| T2DM | 574 | |
| No | 311 | |
| Yes | 263 | |
| HbA1c (mmol/mol ± SD) | 49.07 ± 25.09 | |
| ALT (mean ± SD) | 64.87 ± 43.78 | |
| AST (mean ± SD) | 45.2 ± 29.23 | |
| Platelet (×109) | 232.47 ± 69.40 | |
| Triglycerides (mmol/L) | 3.06 ± 13.69 | |
| Total cholesterol (mmol/L) | 5.42 ± 9.65 | |
| Steatosis grade | 618 | |
| 0 | 36 | |
| 1 | 210 | |
| 2 | 247 | |
| 3 | 125 | |
| Ballooning | 618 | |
| 0 | 136 | |
| 1 | 277 | |
| 2 | 205 | |
| Kleiner lobular Inflammation | 618 | |
| 0 | 88 | |
| 1 | 347 | |
| 2 | 163 | |
| 3 | 20 | |
| Brunt fibrosis stage | 627 | |
| 0 | 147 | |
| 1 | 173 | |
| 2 | 122 | |
| 3 | 132 | |
| 4 | 53 | |
| NAS (mean ± SD) | 618 | 4.04 ± 1.71 |
| NAS score ≥4 | ||
| No | 226 | |
| Yes | 392 |
ALT, alanine aminotransferase; AST, aspartate aminotransferase; HbA1c, haemoglobin A1c; NAS, NASH activity score; NASH, non-alcoholic steatohepatitis; T2DM, type 2 diabetes mellitus.